Defactinib and VS-6766 for the Treatment of Patients With Metastatic Uveal Melanoma
Clinical trial NCT04720417 · TERMINATED
Trial details
- NCT number
- NCT04720417
- Sponsor
- Thomas Jefferson University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-26
- Primary completion
- 2024-04-30
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.